Dr. Irving D Kaplan, MD
Claim this profileStudies Renal Cell Carcinoma
Studies Kidney Cancer
1 reported clinical trial
1 drug studied
Clinical Trials Irving D Kaplan, MD is currently running
More about Irving D Kaplan, MD
Clinical Trial Related12 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Irving D Kaplan, MD has experience with
- CyberKnife
Breakdown of trials Irving D Kaplan, MD has run
Renal Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irving D Kaplan, MD specialize in?
Irving D Kaplan, MD focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage I patients, or patients who are undergoing treatment.
Is Irving D Kaplan, MD currently recruiting for clinical trials?
Yes, Irving D Kaplan, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Irving D Kaplan, MD has studied deeply?
Yes, Irving D Kaplan, MD has studied treatments such as CyberKnife.
What is the best way to schedule an appointment with Irving D Kaplan, MD?
Apply for one of the trials that Irving D Kaplan, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.